Cure Today

Collaboration Lays the Groundwork for Breakthroughs in GIST

This article originally appeared in the January 30th edition of Cure Today. Less than two decades ago, Gleevec (imatinib) drastically changed the frontline treatment for patients with gastrointestinal stromal tumors (GIST). However, as patients [...]

By |2018-10-30T09:20:36-04:00February 24th, 2017|News, Newsletter, Research|
Go to Top